Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Not Making Pricing Changes, Sees Ways To Work With Trump

Executive Summary

Pfizer CEO Ian Read said during the company’s quarterly call that there are ‘lots of ways’ to work with the new Trump administration, his comments coming on the same day several industry leaders met with the new US president.

Advertisement

Related Content

Industry In The Middle: Merck's Frazier Takes A Stand, Trump Tweets Back
Trump Lauds Big Pharma Collaboration On Super Strong Glass Packaging
1Q Pharma Results Preview: Merck, Pfizer, Gilead, Novo Nordisk, Shire, Allergan, Teva
Promise Of US Tax Reform Simmers, But On The Backburner
Novartis Sets 'Flexible Pricing' For Kisqali To Compete Against Pfizer's Ibrance
Stockwatch: Pfizer, Roche, AZ, Novo Prolong Pharmaceutical Winter
Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan
Pfizer Will Support Inflectra Launch With Dedicated Sales Force
Pfizer/Hospira's Biosimilar Pipeline: Substantial Overlap, Limited Divestiture So Far

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC098148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel